HMGB1 and Stroke: Direct blockade of HMGB1 can more completely inhibit the inflammatory response and cellular damage mediated by HMGB1 during the acute phase of stroke, but may affect other physiological processes related to HMGB1, such as DNA repair and gene transcription leading to adverse reactions or side effects.